Abstract: This document provides methods and materials for reducing bacterial induced granulomatous inflammation in a mammal using agents that reduce B7-H1 expression or activity.
Type:
Application
Filed:
May 15, 2013
Publication date:
September 26, 2013
Applicant:
Mayo Foundation for Medical Education and Research
Inventors:
Eugene D. Kwon, John C. Cheville, Thomas J. Sebo, Brant A. Inman
Abstract: An affective model device and a method of deciding the behavior of an affective model device are provided. The affective model device has affective components representing trait, attitude, mood, emotion, and the like. The affective model device updates the emotion at regular time intervals or when a stimulus is received, and decides the behavior based on the updated emotion. The emotion may be updated depending on trait, attitude, and mood.
Type:
Application
Filed:
May 17, 2013
Publication date:
September 26, 2013
Applicants:
Georgia Tech Research Corporation, Samsung Electronics Co., Ltd.
Inventors:
Hyun-Ryong JUNG, Jamee Kim LEE, Lilia MOSHKINA, Ronald ARKIN, Sunghyun PARK, Chien-Ming HUANG
Abstract: A letter confirmation system is provided on a handheld electronic device. The letter confirmation provides highlighting of various letters that have been input to the handheld electronic device during a string of member input actuations. The letter confirmation system can additionally provide predictive linguistic elements that would be appropriate next inputs. Various types of highlights can be provided in various combinations to provide various indications to a user.
Abstract: The present invention relates to a designer or recombinant ubiquitin ligase molecule that includes a toxin binding domain that is specific for a toxin active fragment, wherein the toxin active fragment is an enzymatically active fragment of one or more toxins or toxin serotypes; and an E3-ligase domain that comprises an E3-ligase or polypeptide that facilitates E2-mediated ubiquitination of the toxin active fragment. In an embodiment, the composition further includes a delivery system that allow the designer ubiquitin ligase to enter the cell. The present invention further includes methods for treating an individual intoxicated with a toxin by administering the designer ubiquitin ligase of the present invention.
Abstract: A 3D video encoding rate controlling method and an apparatus using the method are disclosed. An image encoding method includes encoding first and second images at a first encoding ratio, with an encoding rate of the first image different from an encoding rate of the second image and after encoding the first and second images at the first encoding ratio, encoding the first and second images at a second encoding ratio. Accordingly, it may be possible to provide a viewer with 3D images while minimizing visual fatigue in consideration of a human visual characteristics.
Type:
Application
Filed:
October 12, 2012
Publication date:
September 26, 2013
Applicant:
Electronics and Telecommunications Research Institute
Inventors:
Suk Hee CHO, Se Yoon JEONG, Jong Ho KIM, Jin Soo CHOI, Jin Woong KIM
Abstract: A method of treating a subject with elevated levels of peroxynitrite includes administering a therapeutically effective amount of cerium oxide nanoparticles to the subject, wherein the cerium oxide nanoparticles reduce the level of peroxynitrite in the subject.
Type:
Application
Filed:
September 21, 2012
Publication date:
September 26, 2013
Applicant:
University of Central Florida Research Foundation, Inc
Inventors:
William T. Self, Ella Bossy-Wetzel, Sudipta Seal, Janet Dowding
Abstract: A laser element includes a laser rod and a thermally conductive jacket on an exterior surface of the laser rod. The thermally conductive jacket assists in dissipating heat generated in the laser rod during the application of pump energy to the laser rod.
Abstract: The present invention relates to processes for extracting lipid from vegetative plant parts such as leaves, stems, roots and tubers, and for producing industrial products such as hydrocarbon products from the lipids. Preferred industrial products include alkyl esters which may be blended with petroleum based fuels.
Type:
Application
Filed:
March 15, 2013
Publication date:
September 26, 2013
Applicant:
Commonwealth Scientific and Industrial Research Organisation
Inventors:
Thomas Vanhercke, James Robertson Petrie, Anna El Tahchy, Surinder Pal Singh, Qing Liu
Abstract: An authentication server and methods of generating a token for use by a mobile device to establish authorization for the mobile device to access a service provided by a service server, the method comprising receiving a request for the token from the mobile device, generating the token comprising location data identifying a location for the mobile device and authentication data indicating a level of access that the mobile device is permitted to have to the service provided by the service server, and transmitting the token to the mobile device.
Type:
Application
Filed:
March 22, 2012
Publication date:
September 26, 2013
Applicant:
RESEARCH IN MOTION LIMITED
Inventors:
Andrew James Guy Brown, Christopher M. Fogel, Thomas Owen Parry
Abstract: Optically pumped laser structures incorporate reflectors that have high reflectivity and are bandwidth limited to a relatively narrow band around the central laser radiation wavelength. In some cases, the reflectors may be ¾-wavelength distributed Bragg reflectors (DBRs).
Type:
Application
Filed:
March 22, 2012
Publication date:
September 26, 2013
Applicant:
PALO ALTO RESEARCH CENTER INCORPORATED
Inventors:
Thomas Wunderer, John E. Northrup, Mark R. Teepe, Noble M. Johnson
Abstract: The present invention relates to novel quinoxaline, quinazoline and phthalazine derivatives as well as multimeric derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds for the treatment and prevention of brain damage resulting from brain injury, especially secondary brain damage due to traumatic brain injury (TBI). The compounds of the invention are also useful in treating and preventing neurodegenerative diseases.
Type:
Grant
Filed:
August 22, 2006
Date of Patent:
September 24, 2013
Assignee:
Technion Research and Development Foundation Ltd.
Inventors:
Moshe Gavish, Jehuda Arieh Veenman, Alex Shterenberg, Ilan Marek
Abstract: A chiral compound of formula (I) or (II) is provided, wherein each of R1 and R2 independently, is hydrogen, hydroxyl, halogen, amino, nitrile, C1-10 alkyl, or C1-10 alkoxyl. A liquid crystal composition comprising 80-99.5 parts by weight of a liquid crystal host; and 0.5-20 parts by weight of the chiral compound as described above is also provided.
Type:
Grant
Filed:
October 18, 2010
Date of Patent:
September 24, 2013
Assignee:
Industrial Technology Research Institute
Abstract: An electrospinning equipment is provided. The electrospinning equipment includes a power supply, a collector and a material supply electrically connected to the power supply facing the collector and having a spinneret and a guide unit coupled to the spinneret and bent toward the collector, and the spinneret is configured at a central portion of the guide unit.
Type:
Grant
Filed:
March 15, 2010
Date of Patent:
September 24, 2013
Assignees:
National Applied Research Laboratories, Taipei Medical University
Inventors:
Kuen-Wey Shieh, Chien-Chung Chen, Yung-Sheng Lin
Abstract: This invention is to solve the high cost of IV&V by simplifying the complex logistics of project management. This is an intelligent project management system comprising a project server computer remotely accessible by a user computing device. The project server computer includes several databases: A database of electronic library which stores documents that are required by the project, a database which stores project data that reflect the state of the project, and a database which stores the user information of privileged users. Several modules are executing in the project server computer to generate the view of the project, to automatically monitor the state of the project, to verify and validate the mapping between multiple documents for requirement traceability, to automatically indicate the state of the project, to automatically provide assistance to the user, to automatically inform the stakeholder on matters related to the project, and to authenticate the privileged user.
Abstract: A method for communicating state information between a server and a mobile device browser, comprising the steps of providing a control channel between the server and mobile device browser, transmitting at least one message from the mobile device browser to the server over the control channel indicative of browsing-related cache data, and regulating subsequent transmission of data from the server to the mobile device browser based on the at least one message.
Type:
Grant
Filed:
July 21, 2006
Date of Patent:
September 24, 2013
Assignee:
Research In Motion Limited
Inventors:
Michael Knowles, David Tapuska, Tatiana Kalougina
Abstract: A mouse with a humanization of the mIL-3 gene and the mGM-CSF gene, a knockout of a mRAG gene, and a knockout of a mIl2rg subunit gene; and optionally a humanization of the TPO gene is described. A RAG/Il2rg KO/hTPO knock-in mouse is described. A mouse engrafted with human hematopoietic stem cells (HSCs) that maintains a human immune cell (HIC) population derived from the HSCs and that is infectable by a human pathogen, e.g., S. typhi or M. tuberculosis is described. A mouse that models a human pathogen infection that is poorly modeled in mice is described, e.g., a mouse that models a human mycobacterial infection, wherein the mouse develops one or more granulomas comprising human immune cells. A mouse that comprises a human hematopoietic malignancy that originates from an early human hematopoietic cells is described, e.g., a myeloid leukemia or a myeloproliferative neoplasia.
Type:
Grant
Filed:
October 4, 2010
Date of Patent:
September 24, 2013
Assignees:
Regeneron Pharmaceuticals, Inc., Yale University, Institute for Research in Biomedicine
Inventors:
Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan, Tim Willinger, Markus Manz, Anthony Rongvaux, George D. Yancopoulos
Abstract: A thin film magnetic recording head is fabricated by forming a substrate from opposing ferrite blocks which have a ceramic member bonded between them. This structure is then diced to form a plurality of columns, wherein each column has a ferrite/ceramic combination. Each column represents a single channel in the completed head. A block of ceramic is then cut to match the columned structure and the two are bonded together. The bonded structure is then cut or ground until a head is formed, having ceramic disposed between each channel. A ferrite back-gap is then added to each channel, minimizing the reluctance of the flux path. The thin film is patterned on the head to optimize various channel configurations.
Abstract: A connector assembly for optically coupling a first optical device mounted on a first substrate to a second optical device mounted on a second substrate, where the first and second substrates are orthogonally oriented to each other, is presented. The connector assembly includes two connectors. The first connector has an optical waveguide array. The optical waveguide array further includes multiple parallel optical waveguides that are continuously redirected by a mirror oriented at a 45 degree angle to the optical waveguides. Likewise, the second connector also has an optical waveguide array further include multiple parallel optical waveguides continuously redirected by a mirror oriented at a 45 degree angle to the optical waveguides. The first connector is oriented orthogonally to the second connector and the first and second connectors are optically welded together in a back-to-back configuration.
Type:
Grant
Filed:
January 15, 2010
Date of Patent:
September 24, 2013
Assignee:
MAYO Foundation for Medical Education and Research
Inventors:
James N. Kruchowski, Vladimir Sokolov, Mark A. Nelson
Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Type:
Grant
Filed:
May 19, 2009
Date of Patent:
September 24, 2013
Assignee:
The University of Tennessee Research Foundation
Inventors:
Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison